Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
PFIZER’s ZOLOFT IS SECOND SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANT APPROVED BY FDA AFTER LILLY’s PROZAC; LAUNCH SCHEDULED FOR FIRST QUARTER 1992
Jan 06 1992
•
By
The Pink Sheet
More from Archive
More from Pink Sheet